Tansna Therapeutics

Developing a safe, oral anticonvulsant agent that will effectively reduce seizure frequency in patients with epilepsy.

Tansna is a drug discovery and development company founded in 2010 to create and commercialize oral drugs to treat epilepsy. Nearly 1 in 26 people will develop epilepsy in their lifetime. A significant need for more effective and safer antiepileptic drugs remains – indeed, approximately 30% of epilepsy patients are refractory, or unresponsive, to currently available therapeutics. Tansna has discovered novel compounds that are highly effective in several animal models of epilepsy, including refractory epilepsy.